NCT05916469View on ClinicalTrials.gov

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions
Heavy Menstrual BleedingBleeding DisorderVon Willebrand Diseases
Interventions
DRUG

Levonorgestrel Intrauterine System

52 mg levonorgestrel intrauterine system

DRUG

Norethindrone Acetate

norethindrone acetate 5 mg daily

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

Oregon Health and Science University

OTHER